Acadian Asset Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.79M Buy
7,146,022
+787,909
+12% +$969K 0.02% 459
2025
Q1
$6.99M Buy
6,358,113
+1,253,353
+25% +$1.38M 0.02% 402
2024
Q4
$4.62M Buy
5,104,760
+1,156,511
+29% +$1.05M 0.01% 543
2024
Q3
$3.89M Buy
3,948,249
+355,484
+10% +$351K 0.01% 564
2024
Q2
$3.24M Buy
3,592,765
+856,380
+31% +$771K 0.01% 625
2024
Q1
$3.23M Buy
2,736,385
+931,248
+52% +$1.1M 0.01% 562
2023
Q4
$1.64M Buy
1,805,137
+270,475
+18% +$246K 0.01% 725
2023
Q3
$1.28M Sell
1,534,662
-1,532,054
-50% -$1.27M 0.01% 804
2023
Q2
$3.68M Buy
3,066,716
+853,329
+39% +$1.02M 0.02% 535
2023
Q1
$2.79M Buy
2,213,387
+759,647
+52% +$957K 0.01% 622
2022
Q4
$3.15M Buy
+1,453,740
New +$3.15M 0.02% 559